IMRX
Price
$1.69
Change
-$0.04 (-2.31%)
Updated
Dec 18, 04:19 PM (EDT)
77 days until earnings call
URGN
Price
$10.72
Change
-$0.61 (-5.38%)
Updated
Dec 18, 04:34 PM (EDT)
85 days until earnings call
Ad is loading...

IMRX vs URGN

Header iconIMRX vs URGN Comparison
Open Charts IMRX vs URGNBanner chart's image
Immuneering
Price$1.69
Change-$0.04 (-2.31%)
Volume$1.8K
CapitalizationN/A
UroGen Pharma
Price$10.72
Change-$0.61 (-5.38%)
Volume$2.8K
CapitalizationN/A
IMRX vs URGN Comparison Chart
Loading...
IMRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
URGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IMRX vs. URGN commentary
Dec 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMRX is a Hold and URGN is a Hold.

COMPARISON
Comparison
Dec 18, 2024
Stock price -- (IMRX: $1.73 vs. URGN: $11.33)
Brand notoriety: IMRX and URGN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMRX: 78% vs. URGN: 57%
Market capitalization -- IMRX: $53.72M vs. URGN: $478.12M
IMRX [@Biotechnology] is valued at $53.72M. URGN’s [@Biotechnology] market capitalization is $478.12M. The market cap for tickers in the [@Biotechnology] industry ranges from $486.73B to $0. The average market capitalization across the [@Biotechnology] industry is $2.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMRX’s FA Score shows that 0 FA rating(s) are green whileURGN’s FA Score has 0 green FA rating(s).

  • IMRX’s FA Score: 0 green, 5 red.
  • URGN’s FA Score: 0 green, 5 red.
According to our system of comparison, both IMRX and URGN are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMRX’s TA Score shows that 5 TA indicator(s) are bullish while URGN’s TA Score has 3 bullish TA indicator(s).

  • IMRX’s TA Score: 5 bullish, 5 bearish.
  • URGN’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, IMRX is a better buy in the short-term than URGN.

Price Growth

IMRX (@Biotechnology) experienced а -20.28% price change this week, while URGN (@Biotechnology) price change was -5.90% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.65%. For the same industry, the average monthly price growth was +1.43%, and the average quarterly price growth was +4.23%.

Reported Earning Dates

IMRX is expected to report earnings on Mar 05, 2025.

URGN is expected to report earnings on Mar 13, 2025.

Industries' Descriptions

@Biotechnology (-3.65% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
URGN($478M) has a higher market cap than IMRX($53.7M). URGN YTD gains are higher at: -24.467 vs. IMRX (-76.463). IMRX has higher annual earnings (EBITDA): -61.58M vs. URGN (-97.82M). URGN has more cash in the bank: 250M vs. IMRX (50.7M). IMRX has less debt than URGN: IMRX (4.24M) vs URGN (122M). URGN has higher revenues than IMRX: URGN (89.4M) vs IMRX (0).
IMRXURGNIMRX / URGN
Capitalization53.7M478M11%
EBITDA-61.58M-97.82M63%
Gain YTD-76.463-24.467313%
P/E RatioN/AN/A-
Revenue089.4M-
Total Cash50.7M250M20%
Total Debt4.24M122M3%
FUNDAMENTALS RATINGS
URGN: Fundamental Ratings
URGN
OUTLOOK RATING
1..100
75
VALUATION
overvalued / fair valued / undervalued
1..100
77
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
63
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IMRXURGN
RSI
ODDS (%)
Bullish Trend 2 days ago
73%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
83%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
N/A
Bullish Trend 17 days ago
79%
Declines
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 3 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
86%
Aroon
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
82%
View a ticker or compare two or three
Ad is loading...
IMRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
URGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TNXIX19.30N/A
N/A
1290 Avantis U.S. Large Cap Growth I
RIERX12.09N/A
N/A
RBC International Equity R6
PWITX16.59-0.08
-0.48%
PACE International Equity Invmt P2
OAYLX82.02-0.84
-1.01%
Oakmark Select Advisor
CMCCX14.88-0.16
-1.06%
Columbia Select Mid Cap Gro Fd C

IMRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMRX has been loosely correlated with SPRB. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if IMRX jumps, then SPRB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMRX
1D Price
Change %
IMRX100%
N/A
SPRB - IMRX
51%
Loosely correlated
+4.04%
NUVL - IMRX
37%
Loosely correlated
+0.78%
INSM - IMRX
30%
Poorly correlated
+0.63%
ORMP - IMRX
29%
Poorly correlated
-1.67%
SRRK - IMRX
29%
Poorly correlated
+1.82%
More

URGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, URGN has been loosely correlated with CYYNF. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if URGN jumps, then CYYNF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To URGN
1D Price
Change %
URGN100%
+0.27%
CYYNF - URGN
38%
Loosely correlated
N/A
SPRB - URGN
33%
Poorly correlated
+4.04%
IMRX - URGN
28%
Poorly correlated
N/A
ORMP - URGN
28%
Poorly correlated
-1.67%
RZLT - URGN
28%
Poorly correlated
-1.11%
More